Cristcot Announces FDA Acceptance of NDA for Next-Generation Hydrocortisone Acetate (ngHCA) for Treatment of Ulcerative Colitis (UC) of the Rectum

Prescription Drug User Fee Act (PDUFA) target date of October 2026 ---- Submission supported by CESSA Phase 3 trial results demonstrating ...